HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis.

Abstract
Oxidation products of low-density lipoproteins have been suggested to promote inflammation during atherogenesis, and reticulocyte-type 15-lipoxygenase has been implicated to mediate this oxidation. In addition, the 5-lipoxygenase cascade leads to formation of leukotrienes, which exhibit strong proinflammatory activities in cardiovascular tissues. Here, we studied both lipoxygenase pathways in human atherosclerosis. The 5-lipoxygenase pathway was abundantly expressed in arterial walls of patients afflicted with various lesion stages of atherosclerosis of the aorta and of coronary and carotid arteries. 5-lipoxygenase localized to macrophages, dendritic cells, foam cells, mast cells, and neutrophilic granulocytes, and the number of 5-lipoxygenase expressing cells markedly increased in advanced lesions. By contrast, reticulocyte-type 15-lipoxygenase was expressed at levels that were several orders of magnitude lower than 5-lipoxygenase in both normal and diseased arteries, and its expression could not be related to lesion pathology. Our data support a model of atherogenesis in which 5-lipoxygenase cascade-dependent inflammatory circuits consisting of several leukocyte lineages and arterial wall cells evolve within the blood vessel wall during critical stages of lesion development. They raise the possibility that antileukotriene drugs may be an effective treatment regimen in late-stage disease.
AuthorsRainer Spanbroek, Rolf Grabner, Katharina Lotzer, Markus Hildner, Anja Urbach, Katharina Ruhling, Michael P W Moos, Brigitte Kaiser, Tina U Cohnert, Thorsten Wahlers, Arthur Zieske, Gabriele Plenz, Horst Robenek, Peter Salbach, Hartmut Kuhn, Olof Radmark, Bengt Samuelsson, Andreas J R Habenicht
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 100 Issue 3 Pg. 1238-43 (Feb 04 2003) ISSN: 0027-8424 [Print] United States
PMID12552108 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD68 antigen, human
  • RNA, Messenger
  • RNA
  • Arachidonate 15-Lipoxygenase
  • Arachidonate 5-Lipoxygenase
Topics
  • Antigens, CD (biosynthesis)
  • Antigens, Differentiation, Myelomonocytic (biosynthesis)
  • Aorta (enzymology)
  • Arachidonate 15-Lipoxygenase (metabolism)
  • Arachidonate 5-Lipoxygenase (biosynthesis, metabolism)
  • Arteries (enzymology)
  • Arteriosclerosis (pathology)
  • Cell Lineage
  • Endothelium, Vascular (enzymology)
  • Humans
  • Immunoblotting
  • Immunohistochemistry
  • Kinetics
  • Leukocytes (enzymology)
  • Macrophages (enzymology)
  • Phenotype
  • RNA (metabolism)
  • RNA, Messenger (metabolism)
  • Reticulocytes (enzymology)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: